While the global vaccine market is currently lead by GSK, Sanofi, Merck & Co, and Pfizer, various Chinese biotechnology companies have joined the race. Chongqing Zhifei, Hualan Biological Engineering, and Beijing Tiantan Biological Products were among the top Chinese vaccine manufacturers in terms of revenues in the first three quarters of 2019.
Revenue comparison of selected public vaccine enterprises in China from 1st to 3rd quarter of 2019 (in billion yuan)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Vaccination intentions among U.S. adults for 2019-2020 influenza season, by age
- Share of Americans and Canadians who plan to get the flu vaccine next season, 2020
- Share of Americans and Canadians who had the flu vaccine in the past year as of 2020
- Months in which U.S. adults get a flu vaccine as of 2017
- Elderly population immunized against influenza in Spain 2019, by autonomous community
- U.S. adults' reasons against an influenza vaccination for the 2019-2020 flu season
- Flu vaccination coverage among U.S. adults during the 2019-20 flu season, by race
- Burden of rotavirus disease in Asia in absence of immunization
- Vaccinations distributed among international travelers in Italy 2018, by type
- Flu vaccination coverage in Italy 2019-2020, by age group
- Influenza vaccine coverage among Canadian adults as of 2015-2016, by age
- U.S. adults who did not prevent the spread of germs when they had the flu as of 2017
- Growth rate of tourist hotel rooms Taiwan Jan-Sep, 2013
- Reasons for buying products endorsed by influencers Philippines 2020, by age group
- Finolex Cables EBIDTA across India FY 2016-FY 2019
- Fishing nets stock quantity in Japan 2012-2019
- PC monitor & projector market revenue in Thailand 2016-2021
Forward Intelligence (Qianzhan). (March 29, 2020). Revenue comparison of selected public vaccine enterprises in China from 1st to 3rd quarter of 2019 (in billion yuan) [Graph]. In Statista. Retrieved February 27, 2021, from https://www.statista.com/statistics/1192022/china-leading-vaccine-manufacturers-based-on-revenues/
Forward Intelligence (Qianzhan). "Revenue comparison of selected public vaccine enterprises in China from 1st to 3rd quarter of 2019 (in billion yuan)." Chart. March 29, 2020. Statista. Accessed February 27, 2021. https://www.statista.com/statistics/1192022/china-leading-vaccine-manufacturers-based-on-revenues/
Forward Intelligence (Qianzhan). (2020). Revenue comparison of selected public vaccine enterprises in China from 1st to 3rd quarter of 2019 (in billion yuan). Statista. Statista Inc.. Accessed: February 27, 2021. https://www.statista.com/statistics/1192022/china-leading-vaccine-manufacturers-based-on-revenues/
Forward Intelligence (Qianzhan). "Revenue Comparison of Selected Public Vaccine Enterprises in China from 1st to 3rd Quarter of 2019 (in Billion Yuan)." Statista, Statista Inc., 29 Mar 2020, https://www.statista.com/statistics/1192022/china-leading-vaccine-manufacturers-based-on-revenues/
Forward Intelligence (Qianzhan), Revenue comparison of selected public vaccine enterprises in China from 1st to 3rd quarter of 2019 (in billion yuan) Statista, https://www.statista.com/statistics/1192022/china-leading-vaccine-manufacturers-based-on-revenues/ (last visited February 27, 2021)